MedWorld Advisors

View Original

M&A in 2021: What’s Next?

MedWorld CEO Florence Joffroy-Black and Co-Founder Dave Sheppard recently submitted their thoughts on M&A strategies moving forward into 2021, and the impacts of the global pandemic’s effects on earnings. The article covers industry leadership changes, and points to an active M&A landscape moving forward into a post-pandemic environment.

We expect industry strategics to be aggressive in M&A next year with most deals being incremental in nature to bolster portfolios and/or financial performance. However, it will be exciting to watch for the next blockbuster acquisition that will become another dynamic game-changer in the medtech industry.

-Florence Joffroy-Black

To read the full update on M&A activities and projections, view the article on Medical Product Outsourcing’s website below: